CD80 (B7.1) and CD54 (Intracellular Adhesion Molecule-1) Induce Target Cell Susceptibility to Promiscuous Cytotoxic T Cell Lysis

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4347-4353

  Nishio, Makoto ^a,b   Spielman, Julie ^a   Lee, Richard K ^a   Nelson, Debra L ^a   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE PREDISPOSITION; DRUG EFFECT; GENETICS; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; METHODOLOGY; MOUSE; MOUSE MUTANT; UPREGULATION;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; FAS LIGAND PROTEIN; IMMUNIZATION; INTERCELLULAR ADHESION MOLECULE-1; LIGANDS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION;

EID: 0030588613     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
2. Matsui, K., J. J. Boniface, P. A. Reay, H. Schild, B. Fazekas de St. Groth, and M. M. Davis. 1991. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788.
3. Spits, H., W. van Schooten, H. Keizer, G. van Seventer, M. van de Rijn, C. Terhorst, and J. de Vries. 1986. Alloantigen recognition is preceded by non-specific adhesion of cytotoxic T cells and target cells. Science 232:403.
4. Shaw, S., G. E. Luce, R. Quinones, R. E. Gress, T. A. Springer, and M. E. Sanders. 1986. Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones. Nature 323:262.
5. Blanchard, D., C. van Els, J. Borst, S. Carrel, A. Boylston, J. de Vries, and H. Spits. 1987. The role of the T cell receptor, CD8, and LFA-I in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones. J. Immunol 138:2417.
6. Makgoba, M. W., M. E. Sanders, L. G. Ginther, M. L. Dustin, T. Springer, E. A. Clark, P. Mannoni, and S. Shaw. 1988. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature 331:86.
7. Krensky, A. M., E. Robbins, T. A. Springer, and S. J. Burakoff. 1984. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation. J. Immunol. 132:2180.
8. Selvaraj, P., M. L. Plunkett, M. Dustin, M. E. Sanders, S. Shaw, and T. A. Springer. 1987. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 326:400.
9. Altmann, D. M., N. Hogg, J. Trowsdale, and D. Wilkinson. 1989. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 338:512.
10. + cytotoxic T lymphocytes. Eur. J. Immunol. 23:418.
11. Dohlsten, M., G. Hedlund, P. A. Lando, J. Trowsdale, D. Altmann, M. Patarroyo, H. Fischer, and T. Kalland. 1991. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity. Eur. J. Immunol. 21:131.
12. Hara, T., S. M. Fu, and J. A. Hansen. 1985. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 161:1513.
13. Martin, P. J., J. A. Ledbetter, Y. Morishita, C. H. June, P. G. Beatty, and J. A. Hansen. 1986. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J. Immunol. 136:3282.
14. Yang, S. Y., S. M. Denning, S. Mizuno, B. Dupont, and B. F. Haynes. 1988. A novel activation pathway for mature thymocytes: costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation. J. Exp. Med. 168:1457.
15. Damle, N. K., L. V. Doyle, L. S. Grosmaire, and J. A. Ledbetter. 1988. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes. J. Immunol. 140:1753.
16. Van, L. R., M. Brouwer, and L. A. Aarden. 1988. Signals involved in T cell activation: T cell proliferation induced through the synergistic action of antiCD28 and anti-CD2 monoclonal antibodies. Eur. J. Immunol. 18:167.
17. Pierres, A., M. Lopez, C. Cerdan, J. Nunes, D. Olive, and C. Mawas. 1988. Triggering CD28 molecules synergize with CD 2 (T 1L1 and T 1L2)-mediated T cell activation. Eur. J. Immunol. 18:685.
18. Freedman, A. S., G. Freeman, J. C. Horowitz, J. Daley, and L. M. Nadler. 1987. B7, a B-cell-restricted antigen that identifies preactivated B cells. J. Immunol. 139:3260.
19. Yokochi, T., R. D. Holly, and E. A. Clark. 1982. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J. Immunol. 128:823.
20. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
21. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. J. Restivo, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
22. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
23. + T cells. J. Exp. Med. 173:759.
24. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353.
25. Azuma, M., M. Cayabyab, J. H. Phillips, and L. L. Lanier. 1993. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150:2091.
26. Azuma, M., M. Cayabyab, D. Buck, J. Phillips, and L. L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115.
27. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
28. + cytotoxic T lymphocyte-mediated lysis. J. Immunol. 150:4303.
29. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
30. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
31. Horley, K. J., C. Carpenito, B. Baker, and F. Takei. 1989. Molecular cloning of murine intercellular adhesion molecule (ICAM-1). EMBO J. 8:2889.
32. Karasuyama, J., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
33. Hartman, S. C., and R. C. Mulligan. 1988. Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. USA 85:8047.
34. Razi, W. Z., G. J. Freeman, F. Galvin, B. Benacerraf, L. Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen., the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89: 4210.
35. Rouvier, E., M. F. Luciani, and P. Golstein. 1993. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
36. Anel, A., M. Buferne, C. Boyer, V. A. Schmitt, and P. Golstein. 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24:2469.
37. Lee, R. K., J. Spielman, D. Y. Zhao, K. L. Olsen, and E. R. Podack. 1996. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 157:1919.
38. + CTL from Fas ligand/perforin mutant mice. In Proceedings of the Ninth International Congress of Immunology. Federation of American Societies for Experimental Biology, Bethesda, MD, p. A4575.
39. Nishio, M., and E. R. Podack. 1996. Rapid induction of tumor necrosis factor cytotoxicity in naive splenic T cells by simultaneous CD80 (B7.1) and CD54 (ICAM1) co-stimulation. Eur. J. Immunol. 26:2160.
40. Hersey, P., and R. L. Bolhuis. 1990. MHC-unrestricted killing by T cells-multireceptor hypothesis. Immunol. Today 11:110.
41. Lanier, L. L., and J. H. Phillips. 1996. Inhibitory MHC class I receptors on NK and T cells. Immunol. Today 17:86.
42. Springer, T. A., M. L. Dustin, T. K. Kishimoto, and S. D. Marlin. 1987. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu. Rev. Immunol. 5:223.
43. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
44. Patarroyo, M., J. Prieto, J. Rincon, T. Timonen, C. Lundberg, L. Lindbom, B. Asjo, and C. G. Gahmberg. 1990. Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology. Immunol. Rev. 114:67.
45. Shimizu, Y., G. van Seventer, K. J. Horgan, and S. Shaw. 1990. Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol. Rev. 114:109.
46. Azuma, M., J. H. Phillips, and L. L. Lanier. 1992. CD28 co-stimulation of T-cell-mediated cytotoxicity. Int. J. Canc. 7(Suppl):33.
47. Yodoi, J., K. Teshigawara, T. Nikaido, K. Fukui, T. Noma, T. Honjo, M. Takigawa, M. Sasaki, N. Minato, M. Tsudo, and et al. 1985. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL-2 receptor on a natural killer-like cell line (YT cells). J. Immunol. 134:1623.
48. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143:3183.
49. Havele, C., R. C. Bleackley and V. Paetkau. 1986. Conversion of specific to nonspecific cytotoxic T lymphocytes. J. Immunol. 137:1448.
50. Shiver, J. W., and P. A. Henkart. 1991. A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perform gene. Cell 64:1175.
51. Shiver, J. W., L. Su, and P. A. Henkart. 1992. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 71:315.
52. Shi, L., R. P. Kraut, R. Aebersold, and A. H. Greenberg. 1992. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med. 175:553.
53. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977.
54. Vignaux, F., E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781.
55. Kojima, H., N. Shinohara, S. Hanaoka, S. Y. Someya, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, Y. Y. Shinkai, F. W. Alt, A. Matsuzawa, S. Yoneharra, and H. Takayama. 1994. Two distinct pathways of specific killing revealed by perform mutant cytotoxic T lymphocytes. Immunity 1:357.